Epirium
Jeff Bird is currently a Board Member at Epirium. Jeff has previously held positions at Leyden Labs, Foresight Dx, Kriya Therapeutics, Nutcracker Therapeutics, Epirium, Bluebird Ventures, Procyrion, Inc., GRAIL, Inc., and Sutter Hill Ventures.
Jeff Bird received their MD from Stanford University School of Medicine and also has a Ph.D. in Cancer Biology from the same school. Jeff completed their undergraduate studies at Stanford University, earning a Bachelor of Science (BS) degree.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Epirium
Epirium is a clinical-stage biopharmaceutical company that has developed unique insights related to the biology of mitochondrial biogenesis and tissue function, potentially resulting in novel therapeutic approaches to currently intractable neuromuscular diseases.